文献速递心血管MR

多参数心脏磁共振成像鉴别心内膜心肌活检证实的慢性心肌炎与愈合期心肌炎

Multiparametric Cardiac Magnetic Resonance Imaging to Discriminate Endomyocardial Biopsy-Proven Chronic Myocarditis From Healed Myocarditis.
PubMed 文献 · JACC Cardiovasc Imaging · 2024-08-07

本研究前瞻性纳入单中心连续452例症状持续超过30天疑似心肌炎患者,其中103例有可评估的心脏磁共振和心内膜心肌活检参考诊断,53例(51%)为慢性淋巴细胞性心肌炎,50例(49%)为愈合期心肌炎。多参数1.5-T心脏磁共振协议中,节段性T2 mapping(≥3个节段异常)检测慢性心肌炎的准确度最高(92%;95%CI:85-97),鉴别慢性与愈合期心肌炎的AUC为0.87(95%CI:0.79-0.93;P<0.001),优于左心室径向收缩期峰值应变率(0.86)、右心室径向收缩期峰值应变率(0.84)、T1 mapping(0.64)、细胞外容积分数(0.62)和晚期钆增强(0.57)。T2 mapping联合肌钙蛋白或C反应蛋白升高可提高特异度。

要点

  • 节段性T2 mapping(≥3个节段异常)检测慢性心肌炎准确度92%,鉴别慢性与愈合期心肌炎AUC 0.87。
  • 双心室应变分析诊断效能次之:左心室径向收缩期峰值应变率AUC 0.86,右心室0.84。
  • T1 mapping、细胞外容积分数和晚期钆增强鉴别慢性与愈合期心肌炎效能较低(AUC 0.64、0.62、0.57)。

核心结论

  • 多参数心脏磁共振协议可检测持续性心肌炎症并鉴别慢性心肌炎与愈合期心肌炎,节段性T2 mapping和双心室应变分析的诊断准确度高于T1 mapping、细胞外容积分数和晚期钆增强;联合肌钙蛋白或C反应蛋白可能提高特异度。

研究设计与样本

  • 前瞻性单中心研究,连续纳入452例症状持续超过30天疑似心肌炎患者,其中103例有可评估的心脏磁共振和心内膜心肌活检参考诊断;采用多参数1.5-T心脏磁共振协议,包括双心室应变、T1/T2 mapping和晚期钆增强;以心内膜心肌活检为参考标准。

关键影像表现/征象

  • 慢性淋巴细胞性心肌炎53例(51%),愈合期心肌炎50例(49%)。
  • T2 mapping异常定义为≥3个节段异常时,检测慢性心肌炎的准确度为92%(95%CI:85-97)。
  • T2 mapping鉴别慢性与愈合期心肌炎的AUC为0.87(95%CI:0.79-0.93;P<0.001)。
  • 左心室径向收缩期峰值应变率AUC为0.86,右心室径向收缩期峰值应变率AUC为0.84,T1 mapping AUC为0.64,细胞外容积分数AUC为0.62,晚期钆增强AUC为0.57。
  • T2 mapping联合肌钙蛋白或C反应蛋白升高时特异度增加。

诊断标准与关键数值

  • T2 mapping以≥3个节段异常为阈值检测慢性心肌炎,准确度92%(95%CI:85-97),鉴别慢性与愈合期心肌炎AUC 0.87(95%CI:0.79-0.93;P<0.001)。
  • 左心室径向收缩期峰值应变率鉴别慢性与愈合期心肌炎AUC 0.86;右心室径向收缩期峰值应变率AUC 0.84。
  • T1 mapping鉴别慢性与愈合期心肌炎AUC 0.64;细胞外容积分数AUC 0.62;晚期钆增强AUC 0.57。

临床应用与阅片要点

  • 对症状持续超过30天疑似心肌炎患者,可采用多参数心脏磁共振协议评估持续性心肌炎症。
  • 节段性T2 mapping(≥3个节段异常)对鉴别慢性心肌炎与愈合期心肌炎诊断准确度最高,可优先关注。
  • 双心室应变分析(左心室径向收缩期峰值应变率AUC 0.86、右心室0.84)诊断效能次之,可作为辅助指标。
  • T2 mapping联合肌钙蛋白或C反应蛋白升高可提高特异度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Detecting ongoing inflammation in myocarditis patients has prognostic relevance, but there are limited data on the detection of chronic myocarditis and its differentiation from healed myocarditis.

OBJECTIVES: This study sought to assess the performance of cardiac magnetic resonance (CMR) for the detection of ongoing inflammation and the discrimination of chronic myocarditis from healed myocarditis.

METHODS: Consecutive patients with persistent symptoms (>30 days) suggestive of myocarditis were prospectively enrolled from a single tertiary center. All patients underwent a multiparametric 1.5-T CMR protocol including biventricular strain, T1/T2 mapping, and late gadolinium enhancement (LGE). Endomyocardial biopsy was chosen for the reference standard diagnosis.

RESULTS: Among 452 consecutive patients, 103 (median age: 50 years; 66 men) had evaluable CMR and cardiopathologic reference diagnosis: 53 (51%) with chronic lymphocytic myocarditis and 50 (49%) with healed myocarditis. T2 mapping as a single parameter showed the best accuracy in detecting chronic myocarditis, if abnormal in ≥3 segments (92%; 95% CI: 85-97), and provided the best discrimination from healed myocarditis, as defined by the area under the receiver-operating characteristic curve (0.87 [95% CI: 0.79-0.93]; P < 0.001), followed by radial peak systolic strain rate of the left ventricle (0.86) and the right ventricle (0.84); T1 mapping (0.64), extracellular volume fraction (0.62), and LGE (0.57). Specificity increased when T2 mapping was combined with elevation of either troponin or C-reactive protein.

CONCLUSIONS: A multiparametric CMR protocol allows detection of ongoing myocardial inflammation and discrimination of chronic myocarditis from healed myocarditis, with segmental T2 mapping and biventricular strain analysis showing higher diagnostic accuracy compared with T1 mapping, extracellular volume fraction, and LGE. The use of biomarkers (troponin or C-reactive protein) may improve specificity.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Brendel JM, Klingel K, Gräni C, et al. Multiparametric Cardiac Magnetic Resonance Imaging to Discriminate Endomyocardial Biopsy-Proven Chronic Myocarditis From Healed Myocarditis. JACC Cardiovasc Imaging. 2024. PMID: 39115501. doi:10.1016/j.jcmg.2024.06.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。